中際旭創(300308.SZ):雲昌錦質押290.73萬股及提前購回355萬股、悠暉然質押150萬股
格隆匯9月30日丨中際旭創(300308.SZ)公佈,公司於近日接到持股 5%以上股東蘇州益興福企業管理中心(有限合夥)(“益興福”)之一致行動人蘇州雲昌錦企業管理中心(有限合夥)(“雲昌錦”)及蘇州悠暉然企業管理中心(有限合夥)(“悠暉然”)的通知,近日雲昌錦將其持有的部分股票與華泰資管辦理了股票質押交易,將其質押給中信證券的部分股票辦理了提前購回業務;悠暉然將其持有的部分股票與國泰君安辦理了股票質押交易。
其中,雲昌錦質押合計290.73萬股及提前購回合計355萬股,悠暉然質押150萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.